ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Supercomputer Operations To Start In April

November 15, 1985

FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated

November 28, 1975

Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses

June 13, 1986

Scope Of Panel’s Inquiry Outlined In Letter To Members

July 22, 1994

Center Directors Urge NCI To Expand CTEP’s Treatment Referral Cntr.

March 12, 1993

ODAC Oks Melphalan Injection WR-2721 Needs More Data

February 7, 1992